Benedetto C, Zonca M, Giarola M, Maulà V, Chiarolini L, Carandente F
Department of Gynecology and Obstetrics, University of Turin, Italy.
Br J Obstet Gynaecol. 1997 Jun;104(6):682-8. doi: 10.1111/j.1471-0528.1997.tb11978.x.
To investigate the effect of 7 to 14 days of therapy with nifedipine (sustained-release preparation) on the 24-hour blood pressure patterns of pregnant women with pre-eclampsia or chronic hypertension, and to test the utility of blood pressure monitoring in modulating the timing and dosage of the drug.
24-hour automatic blood pressure monitoring of pregnant women with pre-eclampsia or chronic hypertension before and after nifedipine treatment.
Centre for Prevention, Diagnosis and Treatment of Hypertension in Pregnancy, University of Turin, Italy.
Sixteen pregnant women with pre-eclampsia and 17 with chronic hypertension.
24-hour blood pressure monitoring was performed before the beginning of the therapy and after 7 to 14 days of treatment with sustained-release nifedipine.
Chronobiological analysis of systolic and diastolic blood pressure values was performed; MESOR, amplitude, acrophase, hyperbaric index, percent time elevation and significance of rhythm were calculated before and after treatment.
6336 blood pressure measurements were analysed. Systolic and diastolic MESOR values were significantly decreased after nifedipine treatment both in pre-eclampsia and in chronic hypertension. However, the antihypertensive effect of nifedipine in pre-eclampsia was especially pronounced during evening and night, while in chronic hypertension it was more constant during the 24-hour period. 24-hour blood pressure monitoring allowed adjustment, when necessary, to the timing and dosage of nifedipine in accordance with the blood pressure patterns of each patient, using the hyperbaric index and percent time elevation as objective parameters for the evaluation of treatment efficacy.
24-hour blood pressure monitoring is a good method to optimise treatment, and confirms that nifedipine is useful for the control of maternal blood pressure in pregnancy.
探讨硝苯地平(缓释制剂)治疗7至14天对先兆子痫或慢性高血压孕妇24小时血压模式的影响,并检验血压监测在调节药物给药时间和剂量方面的效用。
对先兆子痫或慢性高血压孕妇在硝苯地平治疗前后进行24小时自动血压监测。
意大利都灵大学妊娠高血压预防、诊断和治疗中心。
16例先兆子痫孕妇和17例慢性高血压孕妇。
在治疗开始前以及使用硝苯地平缓释制剂治疗7至14天后进行24小时血压监测。
对收缩压和舒张压值进行时间生物学分析;计算治疗前后的中值、振幅、峰值相位、高压指数、血压升高时间百分比及节律的显著性。
分析了6336次血压测量值。硝苯地平治疗后,先兆子痫和慢性高血压患者的收缩压和舒张压中值均显著降低。然而,硝苯地平对先兆子痫的降压作用在傍晚和夜间尤为明显,而在慢性高血压患者中,24小时内降压作用更为持续。24小时血压监测可在必要时根据每位患者的血压模式调整硝苯地平的给药时间和剂量,将高压指数和血压升高时间百分比作为评估治疗效果的客观参数。
24小时血压监测是优化治疗的良好方法,并证实硝苯地平有助于控制孕期孕妇血压。